Across TCGA pan-cancer cohorts, EPPIN RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated EPPIN data layer compared with 3 for mutation status.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher EPPIN RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated EPPIN expression acts as an unfavorable survival marker, although some lineages such as HNSC and UCEC show a favorable association.
KIRC, COAD, and HNSC are the cancer types where EPPIN RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.